TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE ASSOCIATED WITH EARLY REDUCTIONS IN TISSUE INFLAMMATION: 12 WEEK RESULTS FROM A MAGNETIC RESONANCE IMAGING SUBSTUDY OF A RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Conaghan, Philip G. [1 ,2 ]
Peterfy, Charles G. [3 ]
DiCarlo, Julie [3 ]
Olech, Ewa [4 ]
Alberts, Alan R. [5 ]
Alper, Jeffrey A. [6 ]
Devenport, Jenny [7 ]
Anisfeld, Andrew M. [7 ]
Troum, Orrin M. [8 ]
机构：
[1] Univ Leeds, NIHR Leeds Biomed Res Unit, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England
[3] Spire Sci LLC, San Francisco, CA USA
[4] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[5] W Broward Rheumatol Associates Inc, Tamarac, FL USA
[6] Jeffrey Alper MD Res, Naples, FL USA
[7] Genentech Inc, San Francisco, CA 94080 USA
[8] USC Keck Sch Med, Santa Monica, CA USA
来源：
RHEUMATOLOGY | 2012年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 39 条
  • [1] Early Reductions in Tissue Inflammation with Tocilizumab As Either Monotherapy or in Combination with Methotrexate: 12-Week Unblinded Results From a Magnetic Resonance Imaging Substudy of a Randomized Controlled Trial.
    Conaghan, Philip G.
    Peterfy, Charles G.
    DiCarlo, Julie
    Olech, Ewa
    Alberts, Alan R.
    Alper, Jeffrey A.
    Devenport, Jenny
    Anisfeld, Andrew M.
    Troum, Orrin M.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S165 - S166
  • [2] Tocilizumab Combination Therapy or Monotherapy or Methotrexate Monotherapy in Methotrexate-Naive Patients with Early Rheumatoid Arthritis: 2-Year Clinical and Radiographic Results from a Randomized, Placebo-Controlled Trial.
    Burmester, Gerd
    Rigby, William
    van Vollenhoven, Ronald F.
    Kay, Jonathan
    Rubbert-Roth, Andrea
    Blanco, Ricardo
    Kelman, Ariella
    Dimonaco, Sophie
    Mitchell, Nina
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S811 - S812
  • [3] ADDING TOCILIZUMAB OR SWITCHING TO TOCILIZUMAB MONOTHERAPY IN RA PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE: 24-WEEK RESULTS FROM A RANDOMIZED CONTROLLED STUDY (SURPRISE STUDY)
    Takeuchi, T.
    Kaneko, Y.
    Atsumi, T.
    Tanaka, Y.
    Inoh, M.
    Kobayashi, H.
    Amano, K.
    Miyata, M.
    Murakawa, Y.
    Fujii, T.
    Kawakami, A.
    Yamanaka, H.
    Yamamoto, K.
    Miyasaka, N.
    Mimori, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 62 - 63
  • [4] Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial
    Mease, Philip J.
    Gladman, Dafna D.
    Collier, David H.
    Ritchlin, Christopher T.
    Helliwell, Philip S.
    Liu, Lyrica
    Kricorian, Gregory
    Chung, James B.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (07) : 1112 - 1124
  • [5] Tocilizumab In Combination Therapy and Monotherapy Versus Methotrexate In Methotrexate-Naive Patients With Early Rheumatoid Arthritis: Clinical and Radiographic Outcomes From a Randomized, Placebo-Controlled Trial.
    Burmester, Gerd R.
    Rigby, William
    van Vollenhoven, Ronald F.
    Kay, Jonathan
    Rubbert-Roth, Andrea
    Kelman, Ariella
    Dimonaco, Sophie
    Mitchell, Nina
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1182 - S1183
  • [6] Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial
    Burmester, Gerd R.
    Rigby, William F.
    van Vollenhoven, Ronald F.
    Kay, Jonathan
    Rubbert-Roth, Andrea
    Blanco, Ricardo
    Kadva, Alysha
    Dimonaco, Sophie
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) : 1279 - 1284
  • [7] Modification of Structural Lesions on Magnetic Resonance Imaging By Etanercept: A 12-Week Randomized Placebo-Controlled Trial
    Maksymowych, Walter
    Wichuk, Stephanie
    Dougados, Maxime
    Jones, Heather
    Szumski, Annette
    Marshall, Lisa
    Bukowski, Jack F.
    Lambert, Robert G.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [8] MODIFICATION OF STRUCTURAL LESIONS ON MAGNETIC RESONANCE IMAGING BY ETANERCEPT: A 12-WEEK RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Maksymowych, W. P.
    Wichuk, S.
    Dougados, M.
    Jones, H.
    Szumski, A.
    Marshall, L.
    Bukowski, J. F.
    Lambert, R. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 804 - 805
  • [9] Modification of Structural Lesions on Magnetic Resonance Imaging by Etanercept: A 12-week Randomized Placebo-Controlled Trial
    Maksymowych, Walter
    Wichuk, Stephanie
    Dougados, Maxime
    Jones, Heather
    Szumski, Annette
    Marshall, Lisa
    Bukowski, Jack
    Lambert, Robert
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1232 - 1232
  • [10] TOCILIZUMAB (TCZ) AS COMBINATION THERAPY AND AS MONOTHERAPY VS METHOTREXATE (MTX) IN MTX-NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS: PATIENT-REPORTED OUTCOMES (PROS) FROM A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    Burmester, G.
    Blanco, R.
    Keiserman, M.
    Rigby, W.
    van Vollenhoven, R. F.
    Dimonaco, S. M.
    Grzeschik, S. M.
    Mitchell, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 672 - 672
1234